Anavex Life Sciences (AVXL) Cash & Equivalents (2010 - 2026)
Anavex Life Sciences (AVXL) posted Cash & Equivalents of $118.33 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 17.0% from $101.16 million a year earlier but down 7.1% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Cash & Equivalents came in at $102.58 million, down 22.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 28.5% (FY2020 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Cash & Equivalents was $132.19 million in FY2024 (-12.5%), $151.02 million in FY2023 (+1.3%), $149.16 million in FY2022 (-1.9%) and $152.11 million in FY2021 (+420.0%).
- Quarterly Cash & Equivalents has run from a low of $101.16 million in fiscal Q3 2025 to a high of $154.82 million in fiscal Q3 2023 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with an average decline of 7.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q4 2021, with growth of 420.0%; the weakest was fiscal Q3 2025, with a decline of 27.1%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $127.42 million (Q2 2026), $131.75 million (Q1 2026) and $102.58 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Anavex Life Sciences | 168.71 Mn | -311.37 Mn | - | 118.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.33 Mn |
| Mar 31, 2026 | 127.42 Mn |
| Dec 31, 2025 | 131.75 Mn |
| Sep 30, 2025 | 102.58 Mn |
| Jun 30, 2025 | 101.16 Mn |
| Mar 31, 2025 | 115.77 Mn |
| Dec 31, 2024 | 120.78 Mn |
| Sep 30, 2024 | 132.19 Mn |
| Jun 30, 2024 | 138.76 Mn |
| Mar 31, 2024 | 139.39 Mn |
| Dec 31, 2023 | 143.77 Mn |
| Sep 30, 2023 | 151.02 Mn |
| Jun 30, 2023 | 154.82 Mn |
| Mar 31, 2023 | 153.47 Mn |
| Dec 31, 2022 | 143.62 Mn |
| Sep 30, 2022 | 149.16 Mn |
| Jun 30, 2022 | 153.20 Mn |
| Mar 31, 2022 | 153.34 Mn |
| Dec 31, 2021 | 151.15 Mn |
| Sep 30, 2021 | 152.11 Mn |
API Access
Anavex Life Sciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();